Conduit Pharmaceuticals Stock Price on December 3, 2024
| CDTTW Stock | 0.01 0 28.16% |
If you're considering investing in Conduit Stock, it is important to understand the factors that can impact its price. As of today, the current price of Conduit Pharmaceuticals stands at 0.01, as last reported on the 2nd of March, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. Conduit Pharmaceuticals appears to be out of control, given 3 months investment horizon. Conduit Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0451, which signifies that the company had a 0.0451 % return per unit of risk over the last 3 months. By analyzing Conduit Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.86% is justified by implied risk. Please makes use of Conduit Pharmaceuticals' Downside Deviation of 18.86, mean deviation of 15.21, and Risk Adjusted Performance of 0.095 to double-check if our risk estimates are consistent with your expectations.
At this time, Conduit Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 3.4 B in 2025, whereas Capital Stock is likely to drop 4,767 in 2025. . At this time, Conduit Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to climb to 0.23 in 2025, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.0005). Conduit Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Conduit |
Sharpe Ratio = 0.0451
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDTTW | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 18.97 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.86 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Conduit Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Conduit Pharmaceuticals by adding it to a well-diversified portfolio.
Book Value (9.50) | Shares Float 636.4 K | Shares Short Prior Month 1.3 K | Shares Short 1.3 K |
Related Headline
Inhibrx Headline on 3rd of December 2024
Short Interest in Inhibrx, Inc. Rises By 5.5 by thelincolnianonline.com
Inhibrx, Inc. saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,030,000 shares, an increase of 5.5 percent from the October 31st total of 976,700 shares. Approximately 10.3 percent of the shares of the company are short sold. Based on
Conduit Pharmaceuticals Valuation on December 3, 2024
It is possible to determine the worth of Conduit Pharmaceuticals on a given historical date. On December 3, 2024 Conduit was worth 0.0198 at the beginning of the trading date compared to the closed value of 0.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Conduit Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Conduit Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Conduit Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Conduit Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.02 | 0.02 | 0.02 | 0.02 | 2,822 | |
12/03/2024 | 0.02 | 0.02 | 0.01 | 0.02 | 13,984 |
| 0.02 | 0.02 | 0.01 | 0.01 | 91,122 |
| Backtest Conduit Pharmaceuticals | | | Conduit Pharmaceuticals History | | | Conduit Pharmaceuticals Valuation | Previous | Next |
Conduit Pharmaceuticals Trading Date Momentum on December 3, 2024
| On December 04 2024 Conduit Pharmaceuticals was traded for 0.01 at the closing time. The highest daily price throughout the period was 0.02 and the lowest price was 0.01 . The daily volume was 91.1 K. The net trading volume on 12/04/2024 added to the next day price reduction. The overall trading delta to closing price of the next trading day was 46.00% . The overall trading delta to current closing price is 45.00% . |
Conduit Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Conduit Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Conduit financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Conduit Pharmaceuticals Stock history
Conduit Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Conduit is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Conduit Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Conduit Pharmaceuticals stock prices may prove useful in developing a viable investing in Conduit Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.3 M | 25.4 M |
Conduit Pharmaceuticals Stock Technical Analysis
Conduit Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Conduit Pharmaceuticals Period Price Range
Low | March 2, 2025
| High |
0.00 | 0.00 |
Conduit Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Conduit Pharmaceuticals March 2, 2025 Market Strength
Market strength indicators help investors to evaluate how Conduit Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Conduit Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Conduit Pharmaceuticals stock market strength indicators, traders can identify Conduit Pharmaceuticals entry and exit signals to maximize returns
Conduit Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Conduit Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Conduit Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Conduit to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.095 | |||
| Jensen Alpha | 2.5 | |||
| Total Risk Alpha | 3.19 | |||
| Sortino Ratio | 0.1344 | |||
| Treynor Ratio | (4.19) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.